Roth Capital Assigns Buy On Natus Medical, $33 PT


In a research report issued today, Roth Capital analyst Chris Lewis assigned a Buy rating on Natus Medical (NASDAQ:BABY) with a price target of $33.00.

According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Chris Lewis has a total average return of -9.3% and a 28.6% success rate. Lewis has a 24.1% average return when recommending BABY, and is ranked #3198 out of 3335 analysts.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts